Lifenome Inc. and Optimo Life Launch Genetria, Transforming Precision Health and Longevity in Latin America

Joint venture combines AI-powered genomics with leading longevity care to bring precision health to Mexico and beyond.

NEW YORK - March 27, 2025 - PRLog -- Lifenome Inc., a pioneer in precision health and longevity in the United States, and Optimo Life, a leader in high-end longevity clinics in Mexico, have joined forces to launch Genetria, a groundbreaking joint venture that will bring cutting-edge precision health solutions in longevity and women's health to Mexico and Latin America.

Genetria will serve as a key player in unlocking the $11 billion precision health market in the region, introducing Lifenome's award-winning Genomics AI-powered predictive health solutions to a rapidly growing market in need of hyper-personalized health interventions. The partnership will integrate Lifenome's advanced biological, physiological, and behavioral data-driven health solutions with Optimo Life's expertise in longevity-focused clinics and preventative health strategies.

"Genetria represents a major step in making precision health solutions accessible to a broader global audience. By leveraging our AI-powered genomics technology and Optimo Life's expertise in longevity care, we are empowering individuals across Latin America with the tools to optimize their lifespan and healthspan and improve their quality of life," says Ali Mostashari, PhD, CEO of Lifenome Inc.

Optimo Life, along with its sister company Lonvida, has established itself as a leader in high-end longevity clinics in Mexico, offering science-backed solutions to extend healthspan and improve quality of life. With Genetria, Optimo Life will integrate Lifenome's precision health assessments and interventions into its network, allowing individuals to access the most advanced, personalized longevity and women's health solutions available today.

"The future of health lies in precision and personalization. With Genetria, we are bringing the most advanced predictive and preventative health technologies to Latin America, allowing people to take control of their health like never before. We are excited to partner with Lifenome to revolutionize longevity and women's health across the region," says Alfredo Caravajal, CEO of Optimo Life.

The first product offering of Genetria, called Salud.ia, a precision longevity application powered by DNA and blood testing and wearable data will go live in May in select markets within Mexico. Expansion to other Latin American Countries is slated for 2026-2028.

About LifeNome
LifeNome is a global leader in precision health, offering the world's most advanced Longevity Operating System™ (Longevity OS™) to power personalized health and wellness solutions.

About Optimo Life
Optimo Life, alongside its sister company Lonvida, operates high-end longevity clinics in Mexico, offering science-based preventative health and longevity solutions. The company is at the forefront of personalized medicine, integrating the latest in nutrigenomics, hormone optimization, and cellular therapies to help clients achieve optimal health and extended vitality.